Cns Pharmaceuticals, Inc. · NASDAQ:CNSP

Stonepine Capital Management, LLC reported a 7.90% stake in Cns Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Stonepine Capital Management, LLC reported a 7.90% stake in Cns Pharmaceuticals, Inc., 48,827 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
7.90%
Shares
48,827
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Stonepine Capital Management, LLC7.90%48,827
Stonepine Capital, L.P.7.90%48,827
Stonepine GP, LLC7.90%48,827
Jon M. Plexico7.90%48,827

Source

View original at SEC

Related